{"id":"worldbank.antiretroviral-therapy-coverage.ner.annual","dataset_id":"worldbank-antiretroviral-therapy-coverage","indicator":"antiretroviral-therapy-coverage","geography":"NER","frequency":"annual","unit":"percent","start_period":"2000","end_period":"2024","org":"World Bank","original_indicator":"SH.HIV.ARTC.ZS","url":"https://api.worldbank.org/v2","retrieved_at":"2026-11-07T07:57:03+00:00","version":"1","geography_name":"Niger","region":"Sub-Saharan Africa ","observations":[{"period":"2000","value":0.0,"flags":""},{"period":"2001","value":0.0,"flags":""},{"period":"2002","value":0.0,"flags":""},{"period":"2003","value":0.0,"flags":""},{"period":"2004","value":0.0,"flags":""},{"period":"2005","value":2.0,"flags":""},{"period":"2006","value":4.0,"flags":""},{"period":"2007","value":6.0,"flags":""},{"period":"2008","value":7.0,"flags":""},{"period":"2009","value":17.0,"flags":""},{"period":"2010","value":19.0,"flags":""},{"period":"2011","value":26.0,"flags":""},{"period":"2012","value":31.0,"flags":""},{"period":"2013","value":34.0,"flags":""},{"period":"2014","value":33.0,"flags":""},{"period":"2015","value":38.0,"flags":""},{"period":"2016","value":44.0,"flags":""},{"period":"2017","value":53.0,"flags":""},{"period":"2018","value":61.0,"flags":""},{"period":"2019","value":63.0,"flags":""},{"period":"2020","value":66.0,"flags":""},{"period":"2021","value":68.0,"flags":""},{"period":"2022","value":69.0,"flags":""},{"period":"2023","value":69.0,"flags":""},{"period":"2024","value":66.0,"flags":""}],"indicator_name":"Antiretroviral therapy coverage","topic":"Health","source":"worldbank","provenance":{"organization":"World Bank","original_indicator":"SH.HIV.ARTC.ZS","url":"https://api.worldbank.org/v2","retrieved_at":"2026-11-07T07:57:03+00:00","version":"1","license":"see source"}}